Accéder au contenu
Merck

Expression of glial fibrillary acidic protein in immature oligodendroglia.

Science (New York, N.Y.) (1984-01-27)
B H Choi, R C Kim
RÉSUMÉ

In the human fetal spinal cord at 15 to 16 weeks, glial fibrillary acidic protein (GFAP) was demonstrated within the cytoplasm and processes of cells having the cytological, ultrastructural, and immunocytochemical features of oligodendrocytes--including processes that extend into and contribute to the formation of myelin sheaths. By 17 to 18 weeks, however, GFAP immunoreactivity was no longer evident within such cells. Thus GFAP is expressed by myelin-forming oligodendroglia early in their development.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Glial Fibrillary Acidic Protein (EP672Y) Rabbit Monoclonal Primary Antibody
Sigma-Aldrich
Glial Fibrillary Acidic Protein (GFAP) (SP78) Rabbit Monoclonal Antibody